CN Patent
CN101146521A — 提供包含纤维素和甲基丙烯酸衍生物包衣的口服药物输送系统
Assigned to Sun Pharmaceutical Industries Ltd · Expires 2008-03-19 · 18y expired
What this patent protects
本发明提供口服药物输送系统,该口服药物输送系统包括(a)包含至少一种活性成分,优选抗抑郁剂和药学上可接受的赋形剂的核心,和(b)包围该核心的包衣,所述的包衣含有水不溶性纤维素衍生物和pH依赖性的聚合物,其中水不溶性纤维素衍生物优选地为乙基纤维素,pH依赖性的聚合物优选地为甲基丙烯酸衍生物。
USPTO Abstract
本发明提供口服药物输送系统,该口服药物输送系统包括(a)包含至少一种活性成分,优选抗抑郁剂和药学上可接受的赋形剂的核心,和(b)包围该核心的包衣,所述的包衣含有水不溶性纤维素衍生物和pH依赖性的聚合物,其中水不溶性纤维素衍生物优选地为乙基纤维素,pH依赖性的聚合物优选地为甲基丙烯酸衍生物。
Drugs covered by this patent
- Keppra (levetiracetam) · Generic (originally UCB Pharma)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.